pharmaceutical investing Paratek’s New Drug Applications for Oral and Intravenous Omadacycline Accepted for Priority Review by FDA
pharmaceutical investing Achaogen Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update
Merck Announces U.S. FDA Filing Acceptance of New Drug Application (NDA) for MK-1293, an Investigational Follow-On Biologic Insulin Glargine
Shire Reports Record Full-year Revenue and Strong Double Digit Growth in Non GAAP Diluted Earnings per ADS
SAGA Metals Reports 8 Completed Drill Holes at Trapper North Aimed to Expand the MRE at the Radar Critical Minerals Project
Steadright Begins Exploration at Péribonka Ree-Niobium Carbonatite Target in Quebec's Niobium District
Red Metal Reports Mine Sampling at Farellon, Including 6.8% Copper on Level 7 and 6.05% Copper on Level 9
